US drug administration signals further support for CAR-T cancer treatments
The US Food and Drug Administration has assigned a fast track designation to a new...
The US Food and Drug Administration has assigned a fast track designation to a new...
Shares in biotech company, Prescient Therapeutics, have proved buoyant this week after initial immunogenicity testing...
In an upbeat development, Prescient Therapeutics Limited (ASX:PTX) has announced outstanding findings from in silico...
Shares in Prescient Therapeutics Ltd (ASX: PTX) have surged to fresh heights today on the back of news...
Prescient Therapeutics (PTX) says recent results from testing show its entire platform has been substantially...
The results significantly de-risk the project as PTX continues development of its OmniCAR platform. As...
Tragedy struck the CAR-T space this month with a US company halting a trial of...
In a milestone development regarding its innovative CAR-T cancer therapy programs, Prescient Therapeutics Limited (ASX:PTX) has announced...
Clinical stage oncology company Prescient Therapeutics (ASX:PTX) has announced another crucial step forward in the development of...
Prescient Therapeutics (PTX) has slipped on the ASX today despite announcing some key developments for...
This investor centre was built by Reach Markets
©2022 Reach Markets
To stay up to date with Prescient Therapeutics news and events, please register your details.